All Stories

  1. A Call to Action for the Kidney Community
  2. APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume
  3. Baseline and early outcomes in glomerular disease patients
  4. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker
  5. Retinopathy and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort Study)
  6. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
  7. Integrative Biology Identifies Shared Transcriptional Networks in CKD
  8. Retinopathy and Progression of CKD: The CRIC Study
  9. Increasing Use of Vitamin D Supplementation in the Chronic Renal Insufficiency Cohort Study
  10. Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study
  11. Candidate Gene Association Study of Coronary Artery Calcification in Chronic Kidney Disease
  12. FGF23 Modifies the Relationship Between Vitamin D and Cardiac Remodeling
  13. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
  14. A Longitudinal Study of Left Ventricular Function and Structure from CKD to ESRD: The CRIC Study
  15. Physical Performance and Frailty in Chronic Kidney Disease
  16. Risk Factors for Coronary Artery Calcium Among Patients With Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort Study)
  17. Retinopathy and Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort (CRIC) Study
  18. Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure
  19. Association Between Retinopathy and Cardiovascular Disease in Patients With Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study)
  20. Kidney Function Can Improve in Patients with Hypertensive CKD
  21. Pathogenic Cycle Between the Endogenous Nitric Oxide Synthase Inhibitor Asymmetrical Dimethylarginine and the Leukocyte-Derived Hemoprotein Myeloperoxidase
  22. FGF23 induces left ventricular hypertrophy
  23. Correlates of Osteoprotegerin and Association with Aortic Pulse Wave Velocity in Patients with Chronic Kidney Disease
  24. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
  25. Vitamin D and Subsequent Systolic Hypertension Among Women
  26. Central Pulse Pressure in Chronic Kidney Disease: A Chronic Renal Insufficiency Cohort Ancillary Study
  27. Prevalence of Ocular Fundus Pathology in Patients with Chronic Kidney Disease
  28. Aortic PWV in Chronic Kidney Disease: A CRIC Ancillary Study
  29. Aortic Pulse Pressure Is Associated With Carotid IMT in Chronic Kidney Disease: Report From Chronic Renal Insufficiency Cohort
  30. Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline Characteristics and Associations with Kidney Function
  31. Cum Hoc, Ergo Propter Hoc: Health Disparities Real and Imagined
  32. Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease
  33. Factors associated with enrollment of African Americans into a clinical trial: Results from the African American study of kidney disease and hypertension
  34. Graft and Patient Survival in Kidney Transplant Recipients Selected for de novo Steroid-Free Maintenance Immunosuppression
  35. Arterial Compliance in Adolescents and Young Adults Receiving Chronic Hemodialysis
  36. Insulin’s actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease
  37. 165
  38. Mechanism of lipid enhancement of α1-adrenoceptor pressor sensitivity in hypertension
  39. Quality of Life in the African American Study of Kidney Disease and Hypertension: Effects of Blood Pressure Management
  40. Update on Disparities in the Pathophysiology and Management of Hypertension: Focus on African Americans
  41. Glomerular filtration rate can be accurately predicted using lean mass measured by dual-energy X-ray absorptiometry
  42. Effects of Intravenously Administered Iron on Systemic Blood Pressure in Hemodialysis Patients
  43. Lipids enhance α1-adrenoceptor pressor sensitivity in patients with chronic kidney disease
  44. Lipids enhance α1-adrenoceptor pressor sensitivity in patients with chronic kidney disease
  45. ANEMIA CLINIC: ACHIEVING CONTROL OF ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE.
  46. 116 ANEMIA CLINIC: ACHIEVING CONTROL OF ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE.
  47. Hemodynamic effects of chronic hemodialysis therapy assessed by pulse waveform analysis
  48. Raising lipids acutely reduces baroreflex sensitivity
  49. Lipids Stimulate the Production of 6-keto-prostaglandin F1  in Human Dorsal Hand Veins
  50. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.